Bain ex­ecs Adam Kop­pel and Jef­frey Schwartz line up $125M for their first blank check deal as Wall Street con­tin­ues to em­brace biotech

Adam Kop­pel and Jef­frey Schwartz have jumped in­to the blank check game, rais­ing $125 mil­lion for a stock list­ing in search of a com­pa­ny.

Their SPAC, BCLS Ac­qui­si­tion Corp, raised $125 mil­lion this week, with a line on $25 mil­lion more as it scouts for a biotech in search of mon­ey and a place on Wall Street.

The two prin­ci­pals at Bain Life Sci­ences have been on a romp since they set up the Bain op­er­a­tion 4 years ago. Their S-1 spells out a track record of 22 deals to­tal­ing $650 mil­lion for the life sci­ences group, which led to 9 IPOs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER